| Lineage |
Neuron > Peripheral > Autonomic |
| Markers |
TH, DBH, CGRP |
| Brain Regions |
Celiac Ganglion (Prevertebral) |
| Disease Vulnerability |
Parkinson's Disease, Diabetic Neuropathy |
Celiac Ganglion Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Celiac ganglion neurons are postganglionic sympathetic neurons located in the celiac ganglion, a major prevertebral ganglion of the autonomic nervous system. These neurons provide innervation to the abdominal viscera including the stomach, liver, gallbladder, pancreas, and proximal intestine, and are affected in Parkinson's disease-related dysautonomia and diabetic autonomic neuropathy.
- Position: Anterior to the aorta at the celiac artery origin
- Size: Largest prevertebral ganglion
- Connections: Linked to superior mesenteric and renal ganglia
| Input Source |
Neurotransmitter |
Function |
| Spinal cord (T5-T9) |
Preganglionic ACh |
Primary input |
| Hypothalamus |
Central control |
Autonomic integration |
| Brainstem |
Descending modulation |
Homeostatic regulation |
- Tyrosine Hydroxylase (TH): Catecholamine synthesis
- Dopamine β-Hydroxylase (DBH): Norepinephrine production
- Calcitonin Gene-Related Peptide (CGRP): Sensory transmission
- Neuropeptide Y (NPY): Co-transmitter
| Target Organ |
Primary Function |
Neurotransmitter |
| Stomach |
Motility, secretion |
Norepinephrine |
| Liver |
Metabolism |
Norepinephrine |
| Pancreas |
Insulin, glucagon |
NPY, NE |
| Gallbladder |
Contraction |
Norepinephrine |
- Gastric motility: Inhibitory control
- Intestinal secretion: Modulates absorption
- Pancreatic function: Enzyme and hormone release
- Hepatic glucose output: Sympathetic regulation
- Insulin secretion: Inhibitory modulation
- Lipid metabolism: Adipose tissue innervation
- Splanchnic vasoconstriction: Blood pressure regulation
- Shunt blood flow: Redistribute during stress
PD patients frequently exhibit:
- Gastroparesis: Delayed gastric emptying
- Constipation: Colonic dysmotility
- Postprandial hypotension: Meal-related BP drops
- α-Synuclein deposition: Found in celiac ganglion
- Neuronal degeneration: Reduced norepinephrine
- Glial activation: Inflammatory changes
- Hyperglycemic damage: Microvascular insufficiency
- Oxidative stress: Mitochondrial dysfunction
- Advanced glycation end products: AGEs accumulation
- Gastrointestinal: Nausea, bloating, diarrhea
- Cardiovascular: Resting tachycardia, orthostasis
- Genitourinary: Bladder dysfunction
- Gastric emptying studies: Scintigraphy
- Baroreflex sensitivity: Heart rate variability
- Sudomotor testing: Sweat response
- FDG-PET: Metabolic assessment
- MIBG scan: Sympathetic innervation
- Prokinetic agents: Enhance motility
- α2-agonists: Reduce sympathetic outflow
- Anti-TNF therapy: Address inflammation
- Vagus nerve stimulation: Modulate enteric function
- Gene therapy: Restore catecholamine synthesis
The celiac ganglion is increasingly recognized as a site of early alpha-synuclein pathology in Parkinson's disease:
- Lewy body formation: Intraneuronal inclusions containing phosphorylated alpha-synuclein
- Lewy neurites: Abnormal neuritic processes with alpha-synuclein accumulation
- Propagation hypothesis: Gut-to-brain prion-like spreading via vagus nerve
Celiac ganglion neurons exhibit specific vulnerabilities:
- Long axons: Extensive axonal length increases susceptibility to transport defects
- Metabolic demands: High energy requirements for maintain sympathetic tone
- Oxidative stress: Catecholamine metabolism generates reactive oxygen species
- Mitochondrial dysfunction: Impaired energy production exacerbates degeneration
The celiac ganglion provides potential biomarkers:
- Skin biopsies: Reduced intraepidermal nerve fiber density correlates
- Cardiac MIBG: Reduced uptake indicates sympathetic denervation
- Heart rate variability: Decreased variability marks autonomic impairment
| Approach |
Target |
Status |
| Deep brain stimulation |
STN/GPI |
Improves some autonomic metrics |
| Levodopa |
Dopaminergic |
May worsen dysautonomia |
| Alpha-synuclein antibodies |
Pathological protein |
Clinical trials ongoing |
| Neuroprotective agents |
Mitochondria |
Investigational |
Recent research focuses on:
- Gut-brain axis: Understanding how enteric nervous system pathology spreads to CNS
- Biomarker development: Using autonomic testing to detect early PD
- Gene expression profiling: Identifying molecular signatures of vulnerable neurons
- Stem cell models: Modeling degeneration in patient-derived cells
Research employs various models:
- Transgenic mice: Alpha-synuclein overexpression models
- Patient-derived iPSCs: Autonomic neurons from PD patients
- Organoid systems: Gut-brain axis modeling
Celiac Ganglion Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Celiac Ganglion Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Braak et al., Staging of brain pathology related to sporadic Parkinson's disease (2003)
- Wakabayashi et al., Parkinson's disease: an illness not only of the brain (2018)
- Jellinger, alpha-Synuclein pathology in the peripheral nervous system (2019)
- Kalia & Lang, Parkinson's disease (2015)
- Knudsen et al., Autonomic dysfunction in Parkinson's disease (2018)